{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-002694","form_type":"8-K","ticker":"ACRS","cik":"0001557746","company_name":"Aclaris Therapeutics, Inc.","filed_at":"2026-01-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.422988+00:00","generated_at":"2026-05-16T10:51:44.529990+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Aclaris Therapeutics files 8-K furnishing updated corporate overview; no new financial data disclosed","bullets":["Filed Form 8-K on Jan. 12, 2026, updating its corporate overview presentation (Exhibit 99.1).","Presentation available on company website; no specific financial or operational changes provided in filing.","No earnings, guidance, clinical results, or other material events disclosed in the filing or exhibit."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-002694","json":"https://secwatch.observer/filing/0001104659-26-002694.json","markdown":"https://secwatch.observer/filing/0001104659-26-002694.md","text":"https://secwatch.observer/filing/0001104659-26-002694.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1557746/000110465926002694/0001104659-26-002694-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1557746/000110465926002694/acrs-20260112x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T10:51:44.529990+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}